99mTc(V)-DMSA labelled either by increasing the pH together with a low concentration of Sn, or by increasing the pH only are compared in vitro and in vivo. The gel chromatographic separation shows that after incubation with blood, all the 99mTc(V)-DMSA preparations are stable and do not bind to the plasma proteins. The behavior in rats as well as in clinical studies does not demonstrate any distinctive characteristics between the different radiomolecules. It seems that the pH of the solution is an important factor which controls the formation of 99mTc(V)-DMSA. © 1987.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
PubMed ID: 21507668This study aims to prepare 99mTechnetium Pheophorbide-a (99mTc-PH-A) complex and ...
To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direc...
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...
Introduction: The aim of this study was to find out if Y-90 could form a stabile complex with meso-2...
As a critical step toward elucidating the mechanism of localization of Tc-99m (V) dimercaptosuccinic...
AbstractProtein binding affects tissue distribution, plasma clearance and uptake of renal radiopharm...
This paper engages in the newly prepared bifunctional chelate DTPA-oxn which has a potential use in ...
The purpose of this study was to establish an animal tumour model with squamous carcinoma and use it...
The recent article on optimal handling of dimercaptosuccinic acid (DMSA) raises certain important cl...
AIM: To determine if dimercaptosuccinic acid (DMSA), an agent originally developed as a safe non-tox...
The in vitro stability of 99mTc(Sn)-pyrophosphate solution was examined in dependence on the prepara...
Study of interspecies differences in plasma protein binding of new radiopharmaceuticals Abstract Thi...
Biochemical and histological assays are currently used for the diagnosis and characterization of kid...
BACKGROUND: The reliable method for determination of identity and radiochemical purity (RCP) is of g...
Tc-99m-Hipp as a modified Tc-99m-DTpA, and Tc-99m-PAH as a new renal agent are developed. Each veal ...
PubMed ID: 21507668This study aims to prepare 99mTechnetium Pheophorbide-a (99mTc-PH-A) complex and ...
To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direc...
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...
Introduction: The aim of this study was to find out if Y-90 could form a stabile complex with meso-2...
As a critical step toward elucidating the mechanism of localization of Tc-99m (V) dimercaptosuccinic...
AbstractProtein binding affects tissue distribution, plasma clearance and uptake of renal radiopharm...
This paper engages in the newly prepared bifunctional chelate DTPA-oxn which has a potential use in ...
The purpose of this study was to establish an animal tumour model with squamous carcinoma and use it...
The recent article on optimal handling of dimercaptosuccinic acid (DMSA) raises certain important cl...
AIM: To determine if dimercaptosuccinic acid (DMSA), an agent originally developed as a safe non-tox...
The in vitro stability of 99mTc(Sn)-pyrophosphate solution was examined in dependence on the prepara...
Study of interspecies differences in plasma protein binding of new radiopharmaceuticals Abstract Thi...
Biochemical and histological assays are currently used for the diagnosis and characterization of kid...
BACKGROUND: The reliable method for determination of identity and radiochemical purity (RCP) is of g...
Tc-99m-Hipp as a modified Tc-99m-DTpA, and Tc-99m-PAH as a new renal agent are developed. Each veal ...
PubMed ID: 21507668This study aims to prepare 99mTechnetium Pheophorbide-a (99mTc-PH-A) complex and ...
To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direc...
The goal of this investigation was to examine the possibilities for yttrium-90-labeling of the 2,3-d...